Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 650 of 1467 entries
View as:

Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00252343 Org: User:
Start: 09/30/05 End: 02/28/07 Due: 02/28/08

baSal BoluS Therapy in patIenTs With TypE 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01204593 Org: User:
Start: 11/30/10 End: 01/31/13 Due: 01/31/14

Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03802487 Org: User:
Start: 01/14/19 End: 03/28/19 Due: 03/28/20

Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00452985 Org: User:
Start: 02/28/02 End: 11/30/10 Due: 11/30/11

AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites

Phase: N/A Priority: Normal
NCT ID: NCT00396591 Org: User:
Start: 10/31/06 End: 11/30/08 Due: 11/30/09

DIAMANTE - Diseases Infectious Analysis Microflora Antibiotic Effect

Phase: N/A Priority: Normal
NCT ID: NCT00424905 Org: User:
Start: 12/31/06 End: - Due: -

Relative Bioavailability and Activity of Different Formulations of Insulin Glargine and Lixisenatide in Patients With Diabetes Mellitus Type 1

Phase: N/A Priority: Normal
NCT ID: NCT01146678 Org: User:
Start: 06/30/10 End: 01/31/11 Due: 01/31/12

Pharmacokinetics and Optimal Timing of Dronedarone Initiation Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT01199081 Org: User:
Start: 10/31/10 End: 04/30/12 Due: 04/30/13

Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00664144 Org: User:
Start: 07/31/02 End: 01/31/05 Due: 01/31/06

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00763451 Org: User:
Start: 09/30/08 End: 01/31/11 Due: 01/31/12

Effect of Chronic Supplementation of L-arginine in the Muscular Performance

Phase: N/A Priority: Normal
NCT ID: NCT00785811 Org: User:
Start: 10/31/08 End: 12/31/08 Due: 12/31/09

The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00562809 Org: User:
Start: 07/31/03 End: 08/31/04 Due: 08/31/05

Docetaxel in Non Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00263016 Org: User:
Start: 05/31/05 End: - Due: -

Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione

Phase: N/A Priority: Normal
NCT ID: NCT00044447 Org: User:
Start: 05/31/01 End: 09/30/02 Due: 09/30/03

Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06791291 Org: User:
Start: 06/26/25 End: 03/06/28 Due: 03/06/29

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT06141486 Org: User:
Start: 12/27/23 End: 03/24/28 Due: 03/24/29

A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT06028230 Org: User:
Start: 09/29/23 End: 07/17/26 Due: 07/17/27

Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride

Phase: N/A Priority: Normal
NCT ID: NCT00633425 Org: User:
Start: 10/31/02 End: 10/31/03 Due: 10/31/04

An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice

Phase: N/A Priority: Normal
NCT ID: NCT00576368 Org: User:
Start: 06/30/03 End: 04/30/04 Due: 04/30/05

A Study to Investigate the Disposition of Radio-labeled AVE8062 Compound Administered as a 30-minute IV Infusion to Patients With Advanced Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01063946 Org: User:
Start: 01/31/10 End: 09/30/11 Due: 09/30/12

Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02735044 Org: User:
Start: 04/14/16 End: 12/20/18 Due: 12/20/19

Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00364611 Org: User:
Start: 08/31/06 End: 04/30/12 Due: 04/30/13

Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02520102 Org: User:
Start: 02/28/17 End: 02/28/17 Due: 02/28/18

Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs

Phase: N/A Priority: Normal
NCT ID: NCT01203111 Org: User:
Start: 12/31/10 End: 07/31/12 Due: 07/31/13

Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy

Phase: N/A Priority: Normal
NCT ID: NCT01076764 Org: User:
Start: 04/30/10 End: 05/31/13 Due: 05/31/14